Recorded Chinese product: 天花粉蛋白注射液天花粉蛋白注射液
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 上海金山制药有限公司Chinese legal name: 上海金山制药有限公司
主要成分Active Ingredients
- 结晶天花粉蛋白Jiejing Tianhua Fendan Bai
药物知识说明
结晶天花粉蛋白是一种在国家药监局注册认定的药品。标注生产企业为上海金山制药有限公司。
该药品暂无关联的活性成分信息。
该药品标注的生产企业为：上海金山制药有限公司Chinese legal name: 上海金山制药有限公司、上海金山制药有限公司Chinese legal name: 上海金山制药有限公司、上海金山制药有限公司Chinese legal name: 上海金山制药有限公司。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 天花粉蛋白注射液) is a medicine registered with the national drug regulatory authority. It is manufactured by Chinese legal name: 上海金山制药有限公司.
No active ingredient relationships are currently recorded for this product in MedicineGraph.
Manufacturers recorded for this product: 上海金山制药有限公司Chinese legal name: 上海金山制药有限公司, 上海金山制药有限公司Chinese legal name: 上海金山制药有限公司, 上海金山制药有限公司Chinese legal name: 上海金山制药有限公司.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 天花粉蛋白注射液Recorded Chinese product: 天花粉蛋白注射液
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 注射液1.2mg/ml，皮试0.05mg/ml。Recorded Chinese description: 注射液1.2mg/ml，皮试0.05mg/ml。
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
生产企业Manufacturer
- 上海金山制药有限公司Chinese legal name: 上海金山制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H10870026
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H10870026
Manufacturer
Chinese legal name: 上海金山制药有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H10870026
生产企业
上海金山制药有限公司(国产)
适应症
用于中期妊娠、死胎、过期流产孕妇的引产。对宫外孕、葡萄胎及绒毛膜上皮癌也有一定疗效。
用法用量
肌肉注射1.2～2.4mg作臂部注射宫腔注射用内径1mm的细塑料管，经阴道插入宫腔内胎膜外至宫底或宫腔深度2/3时注射1.2～2.4mg后，再注射2ml注射用水冲洗导管。羊膜腔注射用9号带针芯的长针头选定穿刺点，刺入羊膜腔回抽羊水确证后，再注入本品1.2～2.4mg，回抽羊水2次冲洗针筒内药物。
不良反应
尚不明确。
禁忌
对本品过敏者禁用。
注意事项
1??仔细询问以往曾否使用过天花粉制剂。2??注射本品后48小时内必须卧床休息，严密观察孕妇精神状态、血压、脉搏及呼吸，出现不良反应时应立即对症处理。
贮藏
密闭，在凉暗干燥处保存。
规格
注射液1.2mg/ml，皮试0.05mg/ml。
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.